Literature DB >> 25464477

Ebola therapy: Developing new drugs or repurposing old ones?

Giovanni Lentini1, Solomon Habtemariam2.   

Abstract

Entities:  

Keywords:  Cardiovascular drugs; Ebola; Repurposing

Mesh：

Year:  2014        PMID： 25464477     DOI： 10.1016/j.ijcard.2014.11.092

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.

Authors:  Giovanni Lentini; Maria Maddalena Cavalluzzi; Solomon Habtemariam
Journal:  Molecules       Date:  2020-04-16       Impact factor: 4.411

2.  Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak.

Authors:  T Yan; J Mu; E Qin; Y Wang; L Liu; D Wu; H Jia; Z Li; T Guo; X Wang; Y Qin; Y Li; S Chen; Y Zhang; J Zhang; Y Wu; S Wang; J Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-30       Impact factor: 5.103

3.  Repurposing therapeutic agents and herbal medicines to defeat viral nemesis.

Authors:  Leonardo Caputo; Giovanni Lentini; Solomon Habtemariam
Journal:  Drug Dev Res       Date:  2020-03-30       Impact factor: 4.360
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.